Editas Medicine Aktie
WKN DE: A2AC4K / ISIN: US28106W1036
15.06.2023 15:52:58
|
Editas Medicine Plunges After Pricing 12.5 Mln Share Offering
(RTTNews) - Shares of clinical-stage genome editing company Editas Medicine, Inc. (EDIT) are down more than 13% Thursday morning after it announced pricing of public offering of 12.5 million share at $10 per share.
All of the shares in the offering, which is expected to close on or about June 20, are to be sold by Editas Medicine.
EDIT, currently at $9.62, has traded in the range of $6.33 - $19.97 in the last 52 weeks.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Editas Medicine Incmehr Nachrichten
11.05.25 |
Ausblick: Editas Medicine verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) | |
04.03.25 |
Ausblick: Editas Medicine präsentiert Quartalsergebnisse (finanzen.net) |
Analysen zu Editas Medicine Incmehr Analysen
Aktien in diesem Artikel
Editas Medicine Inc | 1,48 | -2,25% |
|